Robert Dennis Love
Geen lopende functies
Profiel
Robert Dennis Love is Chief Financial Officer of Elusys Therapeutics, Inc. He served as an Executive Vice President and Chief Financial Officer of Alfacell Corp.
and Senior Vice President of Business Partnering and Senior Vice President of Finance and Acquisitions for Quintiles Transnational Corp.
and Innovex.
Mr. Love was Vice President, Director of Strategic Product Development and Chief Financial Officer for SmithKline Beecham Plc.
He began his career as an Accountant at Coopers & Lybrand LLP in 1972.
Mr. Love has 30 years of domestic and international experience in the pharmaceutical industry.
He received a BA degree in Accounting from Rutgers University and an MBA from Villanova University.
Mr. Love is a Certified Public Accountant.
Eerdere bekende functies van Robert Dennis Love
| Bedrijven | Functie | Einde |
|---|---|---|
| Coopers & Lybrand LLP | Corporate Officer/Principal | - |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Financieel Directeur/CFO | - |
Innovex LP
 Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | Financieel Directeur/CFO | - |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Financieel Directeur/CFO | - |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Financieel Directeur/CFO | - |
Opleiding van Robert Dennis Love
| Rutgers State University of New Jersey | Undergraduate Degree |
| Villanova University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | Commercial Services |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
